Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.
about
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosisEarly B-cell Factor gene association with multiple sclerosis in the Spanish population.Atacicept: targeting B cells in multiple sclerosisPathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosisBAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphomaB Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized InflammationThe Ins and Outs of B Cells in Multiple SclerosisEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationBiomarkers in Multiple Sclerosis: An Up-to-Date OverviewPotassium channels, memory T cells, and multiple sclerosisTargeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseasesIgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndromeCcl22/MDC, is a prostaglandin dependent pyrogen, acting in the anterior hypothalamus to induce hyperthermia via activation of brown adipose tissue.Diagnostic biomarkers in multiple sclerosis.Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein.Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid.Lymphoid chemokines in the CNS.Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.Factors supporting intrathecal humoral responses following viral encephalomyelitis.Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.CXCL13 antibody for the treatment of autoimmune disorders.Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.The double-edged sword of autoimmunity: lessons from multiple sclerosis.Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosisUpdate on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targetsLoureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cellsMeasles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSFN-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.Antigen microarrays identify CNS-produced autoantibodies in RRMS.Inflammatory cortical demyelination in early multiple sclerosis.Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection.Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
P2860
Q21144285-B33E964A-DF19-4983-A40A-F1DA4D941DB5Q21261385-9E7A0330-8827-4C14-B3E8-F775E2B8E9B6Q24628925-EC329743-CFD1-415C-A566-FE1898136FACQ24642165-E26604CE-8CA1-4B43-B844-9AB371766E11Q24646563-25C3742E-7CDF-4139-966D-F096663C4FEEQ26770852-B16DC235-93D4-4CE3-8FE0-3B30E3B3B24DQ26776542-4C4EF408-FCDC-46AD-B4C4-EE67ACD703ECQ26830464-73B6C889-B405-47C2-BE0D-05E98A6E3120Q27496017-8D5CFA6E-74FB-4EE5-91E0-CB652A801389Q28281365-BF1F2E77-D4CF-450B-9208-AEEB3254D25EQ28303760-17C83B23-8550-4C09-A6B1-11DB80A41162Q28750403-7847DA8F-E2AE-483C-87CC-2F077C16AF8FQ30498100-85A0A988-1C0B-44C3-B7A1-ED2BC5D606E6Q30598338-A1CB66C4-7461-4BA3-A938-28192D3C2923Q33264770-16B62A58-EF14-42E5-B017-AF5F7B567343Q33565842-3D4AC54D-7B6B-4D2B-94DE-DBC219013B9DQ33745475-75C8FDD7-C519-4766-BF8C-F73FF96A6BEEQ34020894-9DDC2775-537A-4FAD-9AA7-19FEB4DB2BF1Q34059107-3857E147-B199-498B-8DEC-D61D5B3BEF9EQ34251673-0903F077-81B7-40BE-A2C7-D8B38F896889Q34449329-C22E6AFB-627C-4B95-9FAD-1FF9BFF25DD1Q34742821-CBF79426-3B8D-421F-9B61-3E106F901F1EQ35077861-D9D9D7AA-C153-4F7A-985B-B6C61747B4EAQ35086918-AA7FC2C1-3914-4229-BB85-0689E7083A89Q35099828-9437C356-8ACA-46C2-A854-833387E7238DQ35126686-E8F784C6-BE98-47BB-A742-53D294341183Q35155753-33A7B4BA-FAF0-433C-91B2-53F3C96CCB86Q35231795-2A0CAADB-5903-43B0-BD0F-64A4763164ABQ35463552-F388BB12-FF17-4D5C-8E1B-24D0390F9065Q35563291-1E491620-3B8F-4C88-BAAD-7FEB60F5315DQ35755470-9F863102-E144-4FDD-A41D-0BA9DC6C631AQ35756367-F932DE2E-A0E4-4FD6-87D5-EF7BF913CE5CQ35758506-70BFC400-AF16-474F-AD30-59BD105B828AQ35764685-37C751BF-3914-4429-B215-E1D0F2FC0EBEQ35891689-3295BF4E-F3D7-4324-ACFC-C7941312259BQ35947260-32F6ED0F-5622-4540-8DE5-36E5818A9494Q36082102-FC3C5931-E64A-4088-95C2-A16EBE7963ACQ36086261-E876DC90-F78B-4B6C-994B-C23A31EFEC3DQ36091161-EE8434F6-6A1B-4BDF-9C04-C82049B5C59AQ36097325-C1798D70-BC82-4E39-AB94-7A38995B7746
P2860
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recapitulation of B cell diffe ...... ients with multiple sclerosis.
@en
Recapitulation of B cell diffe ...... ients with multiple sclerosis.
@nl
type
label
Recapitulation of B cell diffe ...... ients with multiple sclerosis.
@en
Recapitulation of B cell diffe ...... ients with multiple sclerosis.
@nl
prefLabel
Recapitulation of B cell diffe ...... ients with multiple sclerosis.
@en
Recapitulation of B cell diffe ...... ients with multiple sclerosis.
@nl
P2093
P2860
P50
P356
P1476
Recapitulation of B cell diffe ...... tients with multiple sclerosis
@en
P2093
Anna Corcione
Claudio Gambini
Elisa Ferretti
Emanuela Zappia
Simona Casazza
Vito Pistoia
P2860
P304
11064-11069
P356
10.1073/PNAS.0402455101
P407
P577
2004-07-19T00:00:00Z